Viewing Study NCT05275504

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:07 PM
Ignite Modification Date: 2026-02-24 @ 8:50 AM
Study NCT ID: NCT05275504
Status: UNKNOWN
Last Update Posted: 2022-06-09
First Post: 2022-02-21
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study to Evaluate the Safety and Tolerability of TT-01488 in Patients With B-Cell Malignancies
Sponsor: TransThera Sciences (Nanjing), Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None B-Cell Malignancies View
Keywords:

Keywords

Keyword Brief Keyword Text View
None B-Cell Malignancies View
None Non-Hodgkin's Lymphomas (NHL) View
None BTK inhibitor View
None C481S mutation View